Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Saltro Diagnostic Center for Primary Care, Utrecht, The Netherlands.
Nat Commun. 2022 Aug 12;13(1):4738. doi: 10.1038/s41467-022-31838-8.
Given the emergence of the SARS-CoV-2 Omicron BA.1 and BA.2 variants and the roll-out of booster COVID-19 vaccination, evidence is needed on protection conferred by primary vaccination, booster vaccination and previous SARS-CoV-2 infection by variant. We employed a test-negative design on S-gene target failure data from community PCR testing in the Netherlands from 22 November 2021 to 31 March 2022 (n = 671,763). Previous infection, primary vaccination or both protected well against Delta infection. Protection against Omicron BA.1 infection was much lower compared to Delta. Protection was similar against Omicron BA.1 compared to BA.2 infection after previous infection, primary and booster vaccination. Higher protection was observed against all variants in individuals with both vaccination and previous infection compared with either one. Protection against all variants decreased over time since last vaccination or infection. We found that primary vaccination with current COVID-19 vaccines and previous SARS-CoV-2 infections offered low protection against Omicron BA.1 and BA.2 infection. Booster vaccination considerably increased protection against Omicron infection, but decreased rapidly after vaccination.
鉴于 SARS-CoV-2 奥密克戎 BA.1 和 BA.2 变体的出现以及 COVID-19 加强疫苗的推出,需要有证据表明初级疫苗接种、加强疫苗接种和先前 SARS-CoV-2 变异感染所带来的保护作用。我们采用了一种测试阴性设计,对 2021 年 11 月 22 日至 2022 年 3 月 31 日荷兰社区 PCR 检测的 S 基因靶标失败数据进行了研究(n=671763)。先前的感染、初级疫苗接种或两者都能很好地预防 Delta 感染。与 Delta 相比,对奥密克戎 BA.1 感染的保护作用要低得多。与 BA.2 感染相比,先前感染、初级和加强疫苗接种后,对奥密克戎 BA.1 的保护作用相似。与仅接种疫苗或仅感染的个体相比,同时接种疫苗和先前感染的个体对所有变体的保护作用更高。自上次接种或感染以来,针对所有变体的保护作用随着时间的推移而下降。我们发现,目前的 COVID-19 疫苗的初级接种和先前的 SARS-CoV-2 感染对奥密克戎 BA.1 和 BA.2 感染提供的保护作用较低。加强疫苗接种大大增加了对奥密克戎感染的保护作用,但在接种后迅速下降。